Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL FRUMOVITZ and ANN H KLOPP.
Connection Strength
1.174
-
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. 2021 Jan; 29(1):213-222.
Score: 0.181
-
Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol. 2019 06; 135:58-64.
Score: 0.167
-
Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol. 2018 01; 148(1):132-138.
Score: 0.152
-
Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):546-553.
Score: 0.142
-
Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol. 2016 Dec; 143(3):552-557.
Score: 0.141
-
Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014 Dec; 124(6):1098-1104.
Score: 0.124
-
Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7.
Score: 0.106
-
Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy. 2024 Jan-Feb; 23(1):1-9.
Score: 0.058
-
Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol. 2018 03; 148(3):474-479.
Score: 0.039
-
Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer. 2015 Oct; 25(8):1437-44.
Score: 0.033
-
Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system? Gynecol Oncol. 2015 Feb; 136(2):269-73.
Score: 0.031